|
1
|
Manukonda R, Narayana RV, Kaliki S, Mishra
DK and Vemuganti GK: Emerging therapeutic targets for
retinoblastoma. Expert Opin Ther Targets. 26:937–947. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maçin A, Duman E, Özdemir İ, Öztürk Ş and
Tuncer MC: Hesperidin enhances doxorubicin efficacy by modulating
apoptosis- and migration-associated processes in human
retinoblastoma cells. Biology. 15:3052026. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ancona-Lezama D, Dalvin L and Shields C:
Modern treatment of retinoblastoma: A 2020 review. Indian J
Ophthalmol. 68:23562020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao J, Feng ZX, Wei M, Liu G, Solarte CE,
Li B, Wang YZ, Zhang CY and Gallie BL: Impact of systemic
chemotherapy and delayed enucleation on survival of children with
advanced intraocular retinoblastoma. Ophthalmol Retina. 4:630–639.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kumari A, Singh SP, Kumar P, Kondaveeti
SB, Garg VK, Kaur R, Buttar HS, Sak K, Yadav K and Yadav V: A
comprehensive review of the epidemiology, pathophysiology, risk
factors, and treatment strategies for retinoblastoma. Diseases.
13:3072025. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kamihara J, Bourdeaut F, Foulkes WD,
Molenaar JJ, Mossé YP, Nakagawara A, Parareda A, Scollon SR,
Schneider KW, Skalet AH, et al: Retinoblastoma and neuroblastoma
predisposition and surveillance. Clin Cancer Res. 23:e98–e106.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hosokawa T, Kuntaro D, Takei H, Arakawa Y,
Kambe T, Kurihara J, Mochizuki N, Sato Y and Tanami Y: Assessing
the usefulness of ultrasonography for the diagnosis and evaluation
of Intra-orbital lesions in pediatric patients: A retrospective
analysis. J Ultrasound Med. 43:573–585. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An Iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang D, Chen X, Kang R and Kroemer G:
Ferroptosis: Molecular mechanisms and health implications. Cell
Res. 31:107–125. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abu-Amero KK, Kondkar AA, Almontashiri
NAM, Khan AM, Maktabi AMY, Hameed S and AlMesfer S: Genetics of
retinoblastoma: An overview and significance of genetic testing in
clinical practice. Genes. 16:10312025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zuo YB, Zhang YF, Zhang R, Tian JW, Lv XB,
Li R, Li SP, Cheng MD, Shan J, Zhao Z and Xin H: Ferroptosis in
cancer progression: Role of noncoding RNAs. Int J Biol Sci.
18:1829–1843. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barbi V, De Martino S, Aiello A, Gottardi
Zamperla M, Negri S, Cis L, Pecci V, Nanni S, Farsetti A, Martelli
F, et al: Non-coding RNAs as novel biomarkers and therapeutic
targets in breast cancer. Oncol Rev. 19:16211442025. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng X and Zhang C: The regulation of
Ferroptosis by noncoding RNAs. Int J Mol Sci. 24:133362023.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu J, Qian D and Sun X: Long noncoding
RNAs as potential biomarkers in retinoblastoma: A systematic review
and meta-analysis. Cancer Cell Int. 20:2012020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS J Integr Biol. 16:284–287. 2012. View Article : Google Scholar
|
|
19
|
Ito K and Murphy D: Application of ggplot2
to pharmacometric graphics. CPT Pharmacomet Syst Pharmacol.
2:e792013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: cytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y,
Zhou R, Qiu WJ, Huang N, Sun L, et al: IOBR: Multi-Omics
Immuno-oncology biological research to decode tumor
microenvironment and signatures. Front Immunol. 12:6879752021.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ru Y, Kechris KJ, Tabakoff B, Hoffman P,
Radcliffe RA, Bowler R, Mahaffey S, Rossi S, Calin GA, Bemis L, et
al: The multiMiR R package and database: Integration of
microRNA-target interactions along with their disease and drug
associations. Nucleic Acids Res. 42:e133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiang J, Chen H, Lin Z, Chen J and Luo L:
Identification and experimental validation of ferroptosis-related
gene SLC2A3 is involved in rheumatoid arthritis. Eur J Pharmacol.
943:1755682023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li H and Jin C: Retinoblastoma: Unveiling
molecular pathogenesis and pioneering organoid-driven therapeutic
innovations. Stem Cell Res Ther. 17:962026. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fernández-Acosta R, Vintea I, Koeken I,
Hassannia B and Vanden Berghe T: Harnessing ferroptosis for
precision oncology: Challenges and prospects. BMC Biol. 23:572025.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao L, Zhou X, Xie F and Zhang L, Yan H,
Huang J, Zhang C, Zhou FF, Chen J and Zhang L: Ferroptosis in
cancer and cancer immunotherapy. Cancer Commun. 42:88–116. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Friedmann Angeli JP, Krysko DV and Conrad
M: Ferroptosis at the crossroads of cancer-acquired drug resistance
and immune evasion. Nat Rev Cancer. 19:405–414. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang L, Wang H, Yang X, Wu Q, An P, Jin X,
Liu W, Huang X, Li YZ, Yan S, et al: Auranofin mitigates systemic
iron overload and induces ferroptosis via distinct mechanisms.
Signal Transduct Target Ther. 5:1382020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang ME, Chen J, Lu Y, Bawcom AR, Wu J, Ou
J, Asara JM, Armstrong AJ, Wang QB, Li L, et al: RB1-deficient
prostate tumor growth and metastasis are vulnerable to ferroptosis
induction via the E2F/ACSL4 axis. J Clin Invest. 133:e1666472023.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ji H, Wang W, Li X, Han X, Zhang X, Wang
J, Liu C, Huang L and Gao W: p53: A double-edged sword in tumor
ferroptosis. Pharmacol Res. 177:1060132022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Metcalfe A and Streuli C: Epithelial
apoptosis. Bioessays. 19:711–720. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Frisch SM and Francis H: Disruption of
epithelial cell-matrix interactions induces apoptosis. J Cell Biol.
124:619–626. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zuo S, Wei M, Wang S, Dong J and Wei J:
Pan-cancer analysis of immune cell infiltration identifies a
prognostic immune-cell characteristic score (ICCS) in lung
adenocarcinoma. Front Immunol. 11:12182020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang S, Yang Y, Fang Y, Zhou Q, Sun W,
Zhang Z, Yuan W and Li Z: Targeting tumour-infiltrating B cells:
Mechanisms and advances in cancer therapy. Cell Death Dis.
17:532025. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li C, Jiang P, Wei S, Xu X and Wang J:
Regulatory T cells in tumor microenvironment: New mechanisms,
potential therapeutic strategies and future prospects. Mol Cancer.
19:1162020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Baumjohann D and Brossart P: T follicular
helper cells: Linking cancer immunotherapy and immune-related
adverse events. J Immunother Cancer. 9:e0025882021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kreuger IZM, Slieker RC, Van Groningen T
and Van Doorn R: Therapeutic strategies for targeting CDKN2A loss
in melanoma. J Invest Dermatol. 143:18–25.e1. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Minami JK, Morrow D, Bayley NA, Fernandez
EG, Salinas JJ, Tse C, Zhu H, Su B, Plawat R, Jones A, et al:
CDKN2A deletion remodels lipid metabolism to prime glioblastoma for
ferroptosis. Cancer Cell. 41:1048–1060.e9. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Vuong HG, Ngo TNM and Dunn IF: Prognostic
importance of IDH mutations in chondrosarcoma: An individual
patient data meta-analysis. Cancer Med. 10:4415–4423. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li L, Zhang X, Lin Y, Ren X, Xie T, Lin J,
Wu SM and Ye QN: Let-7b-5p inhibits breast cancer cell growth and
metastasis via repression of hexokinase 2-mediated aerobic
glycolysis. Cell Death Discov. 9:1142023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Poursaei E, Abolghasemi M, Bornehdeli S,
Shanehbandi D, Asadi M, Sadeghzadeh M, Rahmanpour D and Sadeh RN:
Evaluation of hsa-let-7d-5p, hsa-let-7g-5p and hsa-miR-15b-5p
plasma levels in patients with Alzheimer's disease. Psychiatr
Genet. 32:25–29. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Han R, Wang S, Zhou Z, Huang D, Hou J,
Tian M, Ge R and Ma Y: MicroRNA-124-3p suppresses lung cancer by
targeting ITGB1/PI3K/p-AKT signal transduction pathway. Exp Cell
Res. 454:1148522026. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xie Z, Zhong C, Shen J, Jia Y and Duan S:
LINC00963: A potential cancer diagnostic and therapeutic target.
Biomed Pharmacother. 150:1130192022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liang J, Liu C, Xu D, Xie K and Li A:
LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1. J
Transl Med. 20:802022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang W, Min L, Qiu X, Wu X, Liu C, Ma J,
Zhang DY and Zhu LY: Biological Function of Long Non-coding RNA
(LncRNA) Xist. Front Cell Dev Biol. 9:6456472021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Coco-Martin RM, Pastor-Idoate S and Pastor
JC: Cell replacement therapy for retinal and optic nerve diseases:
Cell sources, clinical trials and challenges. Pharmaceutics.
13:8652021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang D, Shen B, Zhang Y, Ni N, Wang Y,
Fan X, Sun H and Gu P: Betacellulin regulates the proliferation and
differentiation of retinal progenitor cells in vitro. J Cell Mol
Med. 22:330–345. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dunn KC, Aotaki-Keen AE, Putkey FR and
Hjelmeland LM: ARPE-19, A human retinal pigment epithelial cell
line with differentiated properties. Exp Eye Res. 62:155–170. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hellinen L, Hagström M, Knuutila H,
Ruponen M, Urtti A and Reinisalo M: Characterization of
artificially re-pigmented ARPE-19 retinal pigment epithelial cell
model. Sci Rep. 9:137612019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jiang A, Wu W, Xu C, Mao L, Ao S, Guo H,
Sun X, Tao J, Sang Y and Huang G: SP2509, a Selective Inhibitor of
LSD1, suppresses retinoblastoma growth by downregulating β-catenin
signaling. Investig Opthalmology Vis Sci. 63:202022. View Article : Google Scholar
|
|
53
|
Fu K, Zhang K and Zhang X: LncRNA HOTAIR
facilitates proliferation and represses apoptosis of retinoblastoma
cells through the miR-20b-5p/RRM2/PI3K/AKT axis. Orphanet J Rare
Dis. 17:1192022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Oshikawa M, Tsutsui C, Ikegami T, Fuchida
Y, Matsubara M, Toyama S, Usami R, Obtoko K and Kato S: Full-length
transcriptome analysis of human retina-derived cell lines ARPE-19
and Y79 using the Vector-capping method. Invest Ophthalmol Vis Sci.
52:6662–6670. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Bai S, Tian B, Li A, Yao Q, Zhang G and Li
F: MicroRNA-125b promotes tumor growth and suppresses apoptosis by
targeting DRAM2 in retinoblastoma. Eye (Lond). 30:1630–1638. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sun QX, Wang RR, Liu N and Liu C:
Dysregulation of miR-204-3p driven by the viability and motility of
retinoblastoma via Wnt/β-catenin pathway in vitro and in vivo.
Pathol Oncol Res. 26:1549–1558. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang H, Qiu X, Song Z, Lan L, Ren X and
Ye B: CircCUL2 suppresses retinoblastoma cells by regulating
miR-214-5p/E2F2 axis. Anticancer Drugs. 33:e218–e227. 2022.
View Article : Google Scholar : PubMed/NCBI
|
